15263-10-2 Usage
Uses
Used in Recreational Drug Industry:
1-(2-FURYL)-3-(4-METHOXYANILINO)-1-PROPANONE is used as a recreational drug for its euphoric and hallucinogenic properties. It is often sought after by individuals looking for an alternative to MDMA and other similar illicit substances.
Used in Research and Development:
1-(2-FURYL)-3-(4-METHOXYANILINO)-1-PROPANONE is used as a research compound for studying its psychoactive effects and potential applications in the field of pharmacology. This helps scientists understand the compound's mechanisms of action and develop new treatments for various conditions.
Used in Drug Regulation and Control:
1-(2-FURYL)-3-(4-METHOXYANILINO)-1-PROPANONE is used as a controlled substance in many countries to regulate its distribution and use. This is due to its potentially harmful effects and association with negative side effects such as anxiety, paranoia, and increased heart rate.
Check Digit Verification of cas no
The CAS Registry Mumber 15263-10-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,2,6 and 3 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 15263-10:
(7*1)+(6*5)+(5*2)+(4*6)+(3*3)+(2*1)+(1*0)=82
82 % 10 = 2
So 15263-10-2 is a valid CAS Registry Number.
15263-10-2Relevant academic research and scientific papers
Diastereoselective synthesis of 4-hydroxypiperidin-2-ones via Cu(I)-catalyzed reductive aldol cyclization
Hon, Wai Lam,Murray, Gordon J.,Firth, James D.
, p. 5743 - 5746 (2007/10/03)
(Chemical Equation Presented) 4-Hydroxypiperidin-2-ones may be prepared in highly diastereoselective fashion using a Cu(I)-catalyzed reductive aldol cyclization of αβ-unsaturated amides with ketones. Used in combination with proline-catalyzed asymmetric M
Synthesis of Heterocyclic Compounds: Part XXVIII - Potential Antileukemic Agents from 3,4-Dihydro-1,3,2-oxazaphosphorin-2-oxides
Sahasrabudhe, S. D.,Tilak, B. D.
, p. 914 - 917 (2007/10/02)
Some 3,6-diaryl-2-chloro-3,4-dihydro-1,3,2-oxazaphosphorin-2-oxides (4a-q, 6a-e and 7a, b) have been synthesised and tested for their anti-leukemic activity.
